To investigate whether MMP9 or FABP4 levels are associated with NAFLD severity, the patients were divided into three groups based on the NAS (HO/NAFLD, borderline or NASH). The gene discussed is FABP4; the disease is metabolic dysfunction-associated steatohepatitis.